Withdrawal of remoxipride
Keks, N.A.; Burrows, G.D.
Medical Journal of Australia 160(9): 591
1994
ISSN/ISBN: 0025-729X PMID: 8018165 Document Number: 435479
Document emailed within 1 workday
Related Documents
Komiyama, T. 1997: Clinical features of alcoholics after alcohol withdrawal--withdrawal syndrome, protracted withdrawal syndrome and prolonged disturbance of alcohol dependence Nihon Rinsho. Japanese Journal of Clinical Medicine 55 Suppl: 393-405Lewander, T.; Westerberg, S.E.; Ogren, S.O.; Von Bahr, C.; Köhler, C. 1990: Remoxipride, a selective antagonist of dopamine D2 receptors, in the treatment of delusional psychoses L'Encephale 16(2): 153-157
Levy, R.; le Maignan, C.; N'Daw, D.; Andrieu, J.M. 1997: An equivalent of anti-androgen withdrawal syndrome: decrease of prostate specific antigen and clinical response to estramustine phosphate withdrawal Presse Medicale 26(13): 611
Eaton, M.J.; Tian, Y.; Lookingland, K.J.; Moore, K.E. 1992: Comparison of the effects of remoxipride and raclopride on nigrostriatal and mesolimbic dopaminergic neuronal activity and on the secretion of prolactin and alpha-melanocyte-stimulating hormone Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 7(3): 205-211
Widman, M.; Nilsson, L.B.; Bryske, B.; Lundström, J. 1993: Disposition of remoxipride in different species. Species differences in metabolism Arzneimittel-Forschung 43(3): 287-297
Soni, S.D.; Tench, D.; Ashwood, T.J.; Movin, G. 1990: Pharmacokinetics of an oral controlled release formulation of remoxipride: a double-blind, crossover comparison with conventional formulation in chronic schizophrenics Acta Psychiatrica Scandinavica. Supplementum 358: 45-47
Ortayli, N.; Bulut, A.şe.; Ozugurlu, M.; Cokar, M. 2005: Why withdrawal? Why not withdrawal? Men's perspectives Reproductive Health Matters 13(25): 164-173
Jantz, L.L. 1977: Withdrawal, healing, and prevention of recurrence. Methods, possibilities and prognosis of withdrawal, healing, and recurrence prevention in alcoholics Zfa. Zeitschrift für Allgemeinmedizin 53(26): 1538-1543
2009: Desvenlafaxine: application withdrawal. Desvenlafaxine: withdrawal of marketing application for depression also Prescrire International 18(103): 197
Pedersen, R.; Førde, R. 2008: Treatment withdrawal Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 128(4): 477; Author Reply 477-8
Morin, R. 1983: The withdrawal of services Nursing Quebec 3(2): 17-19
Parent, M.; Jadot, M.; Toussaint, C.; Masson, A.M. 1982: Alcohol withdrawal Revue Medicale de Liege 37(18): 618-622
Banas, R.; Müller, C.A.; Volkmar, K.; Heinz, A. 2011: Alcohol withdrawal MMW Fortschritte der Medizin 153(14): 70-72
Mareth, T.R.; Brown, T.M. 1996: SSRI withdrawal Journal of Clinical Psychiatry 57(7): 310
Colquhoun, J.P. 1991: Withdrawal wobblies Australian Family Physician 20(6): 844-845
Rutter, J.M. 1991: Withdrawal of Alugan Veterinary Record 128(17): 410
Chiang, W.K.; Goldfrank, L.R. 1990: Substance withdrawal Emergency Medicine Clinics of North America 8(3): 613-631
Berlin, C.S. 1996: Fluoxetine withdrawal symptoms Journal of Clinical Psychiatry 57(2): 93-94
Belloeuf, L.; Le Jeunne, C.; Hugues, F.C. 2000: Paroxetine withdrawal syndrome Annales de Medecine Interne 151 Suppl A: A52-A53
Offerhaus, L. 1979: Propranolol withdrawal syndrome Nederlands Tijdschrift Voor Geneeskunde 123(46): 1988-1990